In 2022, the company that owns the patent of Eriomin funded a small clinical trial involving 45 people, concluding that those who took it over a 12-week period had lower blood glucose and higher GLP-1 than those who took a placebo
The brainstem, which has been implicated to be affected in PASC, explaining the broad spectrum of symptoms, particularly pain and autonomic symptoms [156], has been found to show glucose hypometabolism in patients (among other regions) [47, 53, 89]
Another shot we offer at LIVation is a GLP-1 agonist, but it is also a GIP agonist, meaning it works on both your GLP-1 receptor and gastric inhibitory polypeptide receptor
Proprietary blends: If a product lists glutathione inside a proprietary blend without specifying the exact amount, you have no way to know how much youre actually getting
The answer isnt a simple yes or no, it depends on your fertility goals and where you are in your journey
degraded material is a common source of inconsistent research results